Katrina A.B. Goddard, PhD
Director, Division of Cancer Control and Population Sciences
View Full Curriculum Vitae (PDF)
Dr. Katrina Goddard was appointed Director of the Division of Cancer Control and Population Sciences (DCCPS) in October 2021. In this position, she oversees a division that covers a wide range of scientific domains and disciplines, including epidemiology, behavioral science, surveillance and statistics, cancer survivorship, and health services and outcomes research.
Prior to joining NCI, Dr. Goddard was a Distinguished Investigator and Director of Translational and Applied Genomics at the Kaiser Permanente Center for Health Research (CHR) in Portland, OR. Previous to joining CHR in 2007, she was faculty in the Department of Epidemiology and Biostatistics (now Population and Quantitative Health Sciences) at Case Western Reserve University in Cleveland, OH. She was also a mid-career fellow at the Centers for Disease Control and Prevention in Genetics & Public Health Research and Practice.
Dr. Goddard is a trained genetic epidemiologist who previously focused on public health genomics and the translation of genomic applications into clinical practice. She has directed or collaborated on over 25 federally funded research studies and has held numerous leadership positions on national research consortia. While at Kaiser Permanente, she was the founding director for the NW Biobank, and she was a principal investigator (PI) of the Cancer Health Assessments Reaching Many (CHARM) study as part of the National Human Genome Research Institute (NHGRI)-funded Clinical Sequencing Evidence-Generating Research (CSER) consortium, which has an overarching goal of investigating the integration of genome-scale sequencing into clinical care for diverse and medically underserved individuals. Dr. Goddard was the site PI of the Kaiser Permanente Northwest partner site for the NCI-DCEG Connect for Cancer Prevention Study (Connect), a new prospective cohort seeking to enroll 200,000 adults in the United States from nine integrated health care systems and designed to further investigate the etiology of cancer and its outcomes.
Dr. Goddard has also contributed to knowledge synthesis products that have far-reaching impact for numerous national organizations. She has played key roles in the NIH-funded ClinGen Consortium, directing its Knowledge Synthesis Team—which provides systematic evidence summaries on the ClinGen website for the entire genomics community—and co-chaired the Actionability Working Group. She has served on the board of directors of both the American Society of Human Genetics and the International Genetic Epidemiology Society.
Dr. Goddard received her PhD in biostatistics from the University of Washington and a BS in molecular biology from the University of Wisconsin-Madison.